1-5 of 5
William A. Wegener
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Jhanelle E. Gray, Rebecca S. Heist, Alexander N. Starodub, D. Ross Camidge, Ebenezer A. Kio, Gregory A. Masters, W. Thomas Purcell, Michael J. Guarino, Jamal Misleh, Charles J. Schneider, Bryan J. Schneider, Allyson Ocean, Tirrell Johnson, Leena Gandhi, Kevin Kalinsky, Ronald Scheff, Wells A. Messersmith, Serengulam V. Govindan, Pius P. Maliakal, Boyd Mudenda, William A. Wegener, Robert M. Sharkey, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (19): 5711–5719.
DOI: https://doi.org/10.1158/1078-0432.CCR-17-0933
Published: 01 October 2017
View article
PDF
Includes: Supplementary data
Journal Articles

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Alexander N. Starodub, Allyson J. Ocean, Manish A. Shah, Michael J. Guarino, Vincent J. Picozzi, Jr, Linda T. Vahdat, Sajeve S. Thomas, Serengulam V. Govindan, Pius P. Maliakal, William A. Wegener, Steven A. Hamburger, Robert M. Sharkey, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3870–3878.
DOI: https://doi.org/10.1158/1078-0432.CCR-14-3321
Published: 31 August 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Treatment of Advanced Pancreatic Carcinoma with 90Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial

Seza A. Gulec, Steven J. Cohen, Kenneth L. Pennington, Lionel S. Zuckier, Ralph J. Hauke, Heather Horne, William A. Wegener, Nick Teoh, David V. Gold, Robert M. Sharkey, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4091–4100.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-2579
Published: 15 June 2011
View article
PDF
Journal Articles

Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab

Ola Lindén, Cecilia Hindorf, Eva Cavallin-Ståhl, William A. Wegener, David M. Goldenberg, Heather Horne, Tomas Ohlsson, Lars Stenberg, Sven-Erik Strand, Jan Tennvall
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (14): 5215–5222.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-0172
Published: 20 July 2005
View article
PDF
Journal Articles

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma: Phase I/II Clinical Trial Results

John P. Leonard, Morton Coleman, Jamie C. Ketas, Amy Chadburn, Richard Furman, Michael W. Schuster, Eric J. Feldman, Michelle Ashe, Stephen J. Schuster, William A. Wegener, Hans J. Hansen, Heather Ziccardi, Michael Eschenberg, Urte Gayko, Scott Z. Fields, Alessandra Cesano, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5327–5334.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-0294
Published: 24 August 2004
View article
PDF